Praxis Precision Medicines, Inc. will be presenting at three upcoming investor conferences: the Baird 2025 Global Healthcare Conference, the H.C. Wainwright 27th Annual Global Investment Conference, and the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. Interested investors can schedule one-on-one meetings with the company during these events. A replay of the webcasted events will be available on the company’s website for 90 days. Praxis is a clinical-stage biopharmaceutical company focused on developing therapies for CNS disorders using genetic insights and proprietary platforms. For more information, visit their website and follow them on social media.

Read more at GlobeNewswire: Praxis Precision Medicines to Participate in September